Less use of standard guideline-based treatment of myocardial infarction in patients with chronic kidney disease: A Danish nation-wide cohort study

European Heart Journal

Volumn 34, Issue 37, 2013, Pages 2916-2923

  Blicher, Thalia Marie ^a,b   Hommel, Kristine ^b   Olesen, Jonas Bjerring ^b   Torp Pedersen, Christian ^c   Madsen, Mette ^d   Kamper, Anne Lise ^e  

^a Danish Health and Medicines Authority   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

Angiography; Chronic kidney disease; Coronary revascularization; Myocardial infarction; Pharmacological treatment; Renal replacement therapy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTRATION; RENAL REPLACEMENT THERAPY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANGIOGRAPHY; CHRONIC KIDNEY DISEASE; CORONARY REVASCULARIZATION; MYOCARDIAL INFARCTION; PHARMACOLOGICAL TREATMENT; RENAL REPLACEMENT THERAPY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGED; CARDIOTONIC AGENTS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DENMARK; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTION DRUGS; RENAL INSUFFICIENCY, CHRONIC; TIME-TO-TREATMENT;

EID: 84885358941     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht220     Document Type: Article

References (47)

1. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805.
2. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-1295.
3. Go AS, Chertow GM, Fan D, McCulloch CE, HsuCY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351: 1296-1305.
4. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 2006;70:2021-2030.
5. K/doqi clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005;45:S1-S153.
6. Winkelmayer WC, Charytan DM, Levin R, Avorn J. Poor short-termsurvival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction. Am J Kidney Dis 2006;47:301-308.
7. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensinconverting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003;42:201-208.
8. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-562.
9. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002;137:563-570.
10. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515-1519.
11. Han JH, Chandra A, Mulgund J, Roe MT, Peterson ED, Szczech LA, Patel U, Ohman EM, Lindsell CJ, Gibler WB. Chronic kidney disease in patients with non-st-segment elevation acute coronary syndromes.AmJ Med 2006;119:248-254.
12. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W, Task Force on the Management of Acute Myocardial Infarction of the European Society of C. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003;24:28-66.
13. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39:30-33.
14. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register.Avaluable source of data for modern health sciences. DanMedBull 1999;46:263-268.
15. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011;39:38-41.
16. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-448.
17. Hommel K, Rasmussen S, Madsen M, Kamper AL. The Danish Registry on Regular Dialysis and Transplantation: Completeness and validity of incident patient registration. Nephrol Dial Transplant 2010;25:947-951.
18. So L, Evans D, QuanH. ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res 2006;6:161.
19. Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, Rasmussen S, Kober L, Stender S, Madsen M, Torp-Pedersen C. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J 2006;27:1153-1158.
20. Lentine KL, Villines TC, Xiao H, Schnitzler MA, Brennan DC, Abbott KC, Hauptman PJ. Cardioprotective medication use after acute myocardial infarction in kidney transplant recipients. Transplantation 2011;91:1120-1126.
21. Charytan D, Mauri L, Agarwal A, Servoss S, Scirica B, Kuntz RE. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. Am Heart J 2006;152:558-564.
22. Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, Wallentin L, Jernberg T. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: Data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 2009;120:851-858.
23. Bonello L, De Labriolle A, Roy P, Steinberg DH, Okabe T, Pinto Slottow TL, Xue Z, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Lindsay J, Waksman R. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol 2008;102:535-540.
24. Le Feuvre C, Dambrin G, Helft G, Beygui F, Touam M, Grunfeld JP, Vacheron A, Metzger JP. Clinical outcome following coronary angioplasty in dialysis patients: A case-control study in the era of coronary stenting. Heart 2001;85:556-560.
25. Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, O'Neill WW, Wijns W, Serruys PW. Association of chronic kidney disease with clinical outcomes after coronary revascularization: The Arterial Revascularization Therapies Study (ARTS). Am Heart J 2005;149:512-519.
26. Parikh DS, Swaminathan M, Archer LE, Inrig JK, Szczech LA, Shaw AD, PatelUD. Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. Nephrol Dial Transplant 2010;25:2275-2283.
27. Sunagawa G, Komiya T, Tamura N, Sakaguchi G, Kobayashi T, Murashita T. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis. Ann Thorac Surg 2010;89:1896-1900; discussion 1900.
28. Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA. Survival after coronary revascularization among patients with kidney disease. Circulation 2004;110:1890-1895.
29. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003;92:509-514.
30. Hase H, Nakamura M, Joki N, Tsunoda T, Nakamura R, Saijyo T, Morishita M, Yamaguchi T. Independent predictors of restenosis after percutaneous coronary revascularization in haemodialysis patients. Nephrol Dial Transplant 2001;16: 2372-2377.
31. Chertow GM, Normand SL, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project. Am J Kidney Dis 2000;35:1044-1051.
32. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA.Acomparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995;25:281-290.
33. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002;144:226-232.
34. Januzzi JL, Cannon CP, DiBattiste PM, Murphy S, Weintraub W, Braunwald E, Investigators T-T. Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). Am J Cardiol 2002;90:1246-1249.
35. Medi C, Montalescot G, Budaj A, Fox KA, Lopez-Sendon J, FitzGerald G, Brieger DB, Investigators G. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: Grace (Global Registry of Acute Coronary Events). JACC. Cardiovasc Interv 2009;2:26-33.
36. Amin AP, Salisbury AC, McCullough PA, Gosch K, Spertus JA, Venkitachalam L, Stolker JM, Parikh CR, Masoudi FA, Jones PG, Kosiborod M. Trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med 2012;172:246-253.
37. Gibney EM, Casebeer AW, Schooley LM, Cunningham F, Grover FL, Bell MR, McDonald GO, Shroyer AL, Parikh CR. Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: A National Veterans Administration Study. Kidney Int 2005;68:826-832.
38. Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, Mehta SR, Yusuf S, Investigators CT. Renal function and outcomes in acute coronary syndrome: Impact of clopidogrel. Eur J Cardiovasc Prev Rehabil 2007;14:312-318.
39. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002;288:2411-2420.
40. Best PJ, Steinhubl SR, Berger PB, Dasgupta A, Brennan DM, Szczech LA, Califf RM, Topol EJ. The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial. Am Heart J 2008;155:687-693.
41. Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, Wallentin L, Jernberg T. Association between statin treatment and outcome in relation to renal function in survivors of myocardial infarction. Kidney Int 2011;79: 997-1004.
42. Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Imai R, Yamazaki S, Okino K, Iwamoto N, Takahashi H, Ono T. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: A randomized trial. Am J Kidney Dis 2009;54:307-317.
43. McCullough PA, Sandberg KR, Yee J, Hudson MP. Mortality benefit of angiotensinconverting enzyme inhibitors after cardiac events in patients with end-stage renal disease. J Renin Angiotensin Aldosterone Syst 2002;3:188-191.
44. Reddan DN, Szczech L, Bhapkar MV, Moliterno DJ, Califf RM, Ohman EM, Berger PB, Hochman JS, Van deWerf F, Harrington RA, NewbyLK. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial Transplant 2005;20:2105-2112.
45. Herzog CA, Littrell K, Arko C, Frederick PD, Blaney M. Clinical characteristics of dialysis patients with acute myocardial infarction in the united states: A collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 2007;116:1465-1472.
46. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: A comparison of mortality and hospital discharge data with the Danish Monica Registry. J Clin Epidemiol 2003; 56:124-130.
47. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD, Acute Coronary T, Intervention Outcomes Network r. Use of evidence-based therapies inshort-termoutcomesof ST-segmentelevationmyocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. Circulation 2010;121:357-365.